Navigation Links
Large-scale investment catapults CAMH's mental illness and addiction research forward
Date:8/20/2008

The Centre for Addiction and Mental Health (CAMH) is proud to announce a landmark investment of $15 million by the Canada Foundation for Innovation (CFI) into research that will propel the understanding, intervention, treatment and prevention of mental illness and addiction to the next level of excellence.

This funding from the Large-Scale Institutional Endeavours component of CFI's Research Hospital Fund will allow CAMH to leverage our scientific strengths, and transform lives with a new integrated, multi-disciplinary and innovative research environment.

"This unparalleled support and endorsement is the engine that will drive real change for people impacted by mental illness and addiction," said CAMH Vice President of Research Dr. Bruce Pollock today. "The new environment that we can now build as part of our bold redevelopment will greatly increase the opportunities for researchers, clients, and partners to work together to generate timely, relevant research that can seamlessly translate into clinical practice that provides optimal care."

CFI's contribution, the largest individual grant in CAMH's history, kicks off a $38 million project that will enable CAMH to focus on transforming lives across six research themes: Schizophrenia, Mood Disorders, Addictions, Community Health & Knowledge Exchange, Neuroimaging, Pharmacogentics and Neuroscience. With the additional financial support coming from donors through the CAMH Foundation, this integrated and pioneering project will address key issues such as;

  • Optimizing treatment across mental illness and substance use disorders, including the development of individualized treatment based on molecular genetics

  • Translating discoveries into improved clinical practice, prevention and intervention strategies

  • Reaching out to underserved and understudied communities such as First Nations, remote populations, the workplace, women, the elderly, and children.

"As we celebrate CAMH's 10th anniversary and officially open the first phase of our redeveloping Queen Street site, we're also witnessing a turning point in the history of mental illness and addiction research, thanks to the generosity, support and faith of CFI," said CAMH President and CEO Dr. Paul Garfinkel. "Due to stigma, psychiatry and addiction treatment are behind many other areas of medicine. This support provides many of the tools we need to dramatically improve client, community and workplace health, reduce the burden of these diseases and their impact on the health care system."

"CAMH's proposal brings together a group of outstanding researchers to advance a world-class, innovative research agenda," according to CFI's International Assessment Committee. "The proposed research will be an important factor in enhancing knowledge and public awareness of mental health and addictions."


'/>"/>

Contact: Michael Torres
michael_torres@camh.net
416-595-6015
Centre for Addiction and Mental Health
Source:Eurekalert

Related biology news :

1. Open access to large-scale drug discovery data
2. Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems
3. Surprising discovery from first large-scale analysis of biodiversity and biogeography of viruses
4. Are existing large-scale simulations of water dynamics wrong?
5. Texas Hospital nations first to use large-scale cocoon strategy against whooping cough
6. Microarray sequence capture speeds large-scale resequencing of targeted genomic regions
7. Europe-wide investment in lipid research will help tackle disease, says new report
8. Sanitation investment in poor countries would yield $9-to-1 benefits in productivity, health: UN
9. Using live fish, new tool a sentinel for environmental contamination
10. Experimental chemotherapy regimen shows promise in treating advanced lung cancer
11. L-1 Identity Solutions to Hold Supplemental Second Quarter 2008 Financial Results Q&A Conference Call at 2:00p.m. (ET) Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2018)... ... August 13, 2018 , ... NRD, ... P-2021-5502 and P-2021-5602 Cleanroom Ionizing Gun. , The ionizing gun features ergonomic ... P-2021 ionizing cartridge, 0.5-micron filter and electropolished OSHA-compliant tip. This can be cleanroom ...
(Date:8/14/2018)... ... August 14, 2018 , ... ActiGraph , ... global scientific community, announced today the establishment of a new Scientific Affairs and ... foster and support scientific collaborations with ActiGraph’s academic and pharmaceutical industry partners to ...
(Date:8/14/2018)... ... August 14, 2018 , ... From reconstruction of craniofacial ... a better understanding of congenital heart defects, 3-D printing is providing exciting approaches ... issue of Birth Defects Research (DOI: 10.1002/bdr2.1367). , The ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... SAN MATEO, Calif. (PRWEB) , ... July 25, ... ... innovator for in vivo research utilizing its state-of-the-art Digital Vivarium™ and Vium Cloud ... Laura Schaevitz, Ph.D., to Chief Scientific Officer. Additionally, the company announced the appointment ...
(Date:7/25/2018)... , ... July 25, 2018 , ... ... for managing clinical trial patient and supplies data through its flagship IXRS® ... on IRT: Best Practices.” , This podcast features both Almac thought leaders and ...
(Date:7/24/2018)... , ... July 23, 2018 , ... ... a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, and immune ... function response assessed in the preclinical research were significantly reduced. Results are as ...
(Date:7/24/2018)... WORTH, Texas (PRWEB) , ... July 24, 2018 , ... ... (BSA) to support blood bank reagent suppliers. In Boval’s early days most of ... capabilities were added to produce BSA for diagnostic purposes after gel cards changed that ...
Breaking Biology Technology: